Schindler, Suzanne E. http://orcid.org/0000-0002-1680-1465
Bateman, Randall J.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (K23AG053426)
Article History
First Online: 14 January 2021
Competing interests
: R.J.B. co-founded C2N Diagnostics. Washington University and R.J.B. have equity ownership interest in C2N Diagnostics and receive royalty income based on technology (stable isotope labeling kinetics and blood plasma assay) licensed by Washington University to C2N Diagnostics. R.J.B. receives income from C2N Diagnostics for serving on the Scientific Advisory Board. Washington University, with R.J.B. as co-inventor, have filed patent applications (US Patent application nos. 16/610,428; 62/898,407; 62/962,296; PCT/US2020/012959) on technology related to the processes described in this article. R.J.B. has received honoraria as a speaker/consultant/advisory board member from Amgen, AC Immune, Eisai, F. Hoffman-LaRoche and Janssen, and reimbursement of travel expenses from AC Immune, F. Hoffman-La Roche and Janssen. S.E.S. declares no competing interests.